{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:54:05Z","timestamp":1795024445339,"version":"4.10.2"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.diabres.2022.109235","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T02:40:41Z","timestamp":1644028841000},"page":"109235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Common variants in genes involved in islet amyloid polypeptide (IAPP) processing and the degradation pathway are associated with T2DM risk: A Chinese population study"],"prefix":"10.1016","volume":"185","author":[{"given":"Jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2022.109235_b0005","unstructured":"International Diabetes Federation. IDF Diabetes Atlas [Internet], 2019. 9th ed. Brussels, Belgium, International Diabetes Federation. Available from http:\/\/www .diabetesatlas.org. Accessed 11 November 2019."},{"issue":"7614","key":"10.1016\/j.diabres.2022.109235_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature18642","article-title":"The genetic architecture of type 2 diabetes","volume":"536","author":"Fuchsberger","year":"2016","journal-title":"Nature"},{"issue":"7624","key":"10.1016\/j.diabres.2022.109235_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature19806","article-title":"Genome-wide associations for birth weight and correlations with adult disease","volume":"538","author":"Horikoshi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2022.109235_b0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol Rev"},{"issue":"7","key":"10.1016\/j.diabres.2022.109235_b0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","article-title":"Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils","volume":"27","author":"Cao","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.diabres.2022.109235_b0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of beta-cell prohormone convertase (PC)1\/3 in processing of pro-islet amyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0040","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","article-title":"Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death","volume":"55","author":"Marzban","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0045","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1210\/en.2004-1175","article-title":"Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells","volume":"146","author":"Marzban","year":"2005","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.diabres.2022.109235_b0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-016-4174-2","article-title":"Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide","volume":"60","author":"Courtade","year":"2017","journal-title":"Diabetologia"},{"issue":"47","key":"10.1016\/j.diabres.2022.109235_b0055","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1016\/j.diabres.2022.109235_b0060","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/ja1007867","article-title":"Role of zinc in human islet amyloid polypeptide aggregation","volume":"132","author":"Brender","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"68","key":"10.1016\/j.diabres.2022.109235_b0065","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1039\/C7CC04291D","article-title":"Zinc-coordination and C-peptide complexation: a potential mechanism for the endogenous inhibition of IAPP aggregation","volume":"53","author":"Ge","year":"2017","journal-title":"Chem Commun (Camb)"},{"issue":"9","key":"10.1016\/j.diabres.2022.109235_b0070","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diab.45.9.1279","article-title":"Missense mutation of amylin gene (S20G) in Japanese NIDDM patients","volume":"45","author":"Sakagashira","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.2040-1124.2011.00102.x","article-title":"Progressive deterioration of insulin secretion in Japanese type 2 diabetic patients in comparison with those who carry the S20G mutation of the islet amyloid polypeptide gene: A long-term follow-up study","volume":"2","author":"Morita","year":"2011","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.diabres.2022.109235_b0080","doi-asserted-by":"crossref","first-page":"e62378","DOI":"10.1371\/journal.pone.0062378","article-title":"Genetic associations of type 2 diabetes with islet amyloid polypeptide processing and degrading pathways in asian populations","volume":"8","author":"Lam","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.diabres.2022.109235_b0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/diabetes.52.5.1300","article-title":"Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility","volume":"52","author":"Groves","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2022.109235_b0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s001250050971","article-title":"Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity","volume":"41","author":"Utsunomiya","year":"1998","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.diabres.2006.07.030","article-title":"Amylin S20G mutation in Mexican population","volume":"76","author":"Garcia-Gonzalez","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"2-3","key":"10.1016\/j.diabres.2022.109235_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8227(00)00142-X","article-title":"S20G mutation of the amylin gene in Japanese patients with type 2 diabetes","volume":"49","author":"Hayakawa","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s001250050878","article-title":"Glucose tolerance in Japanese subjects with S20G mutation of the amylin gene","volume":"41","author":"Yamada","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109235_b0110","article-title":"Pancreatic beta cell-selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis. JCI","volume":"6","author":"Xu","year":"2021","journal-title":"Insight"},{"issue":"5829","key":"10.1016\/j.diabres.2022.109235_b0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1126\/science.1142382","article-title":"A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants","volume":"316","author":"Scott","year":"2007","journal-title":"Science"},{"issue":"7130","key":"10.1016\/j.diabres.2022.109235_b0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.diabres.2022.109235_b0125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00125-008-0982-3","article-title":"Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study)","volume":"51","author":"Hertel","year":"2008","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabres.2022.109235_b0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-008-0926-y","article-title":"Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion","volume":"51","author":"Kirchhoff","year":"2008","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.diabres.2022.109235_b0135","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.2337\/db07-1583","article-title":"Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A\/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians","volume":"57","author":"Ng","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2022.109235_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00109-007-0295-x","article-title":"Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study","volume":"86","author":"Cauchi","year":"2008","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"10.1016\/j.diabres.2022.109235_b0145","doi-asserted-by":"crossref","first-page":"e15542","DOI":"10.1371\/journal.pone.0015542","article-title":"Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese","volume":"5","author":"Hu","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2022.109235_b0150","unstructured":"World Health Organization. Definition, diagnosis and classification of dia- betes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999."},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0662-7","article-title":"Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients","volume":"17","author":"Wang","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2022.109235_b0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/diacare.24.4.796","article-title":"Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times","volume":"24","author":"Stumvoll","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109235_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2022.109235_b0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0168-8227(03)00019-6","article-title":"S20G mutation of the amylin gene is associated with a lower body mass index in Korean type 2 diabetic patients","volume":"60","author":"Cho","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.diabres.2022.109235_b0175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","article-title":"Leveraging Polygenic Functional Enrichment to Improve GWAS Power","volume":"104","author":"Kichaev","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"D1","key":"10.1016\/j.diabres.2022.109235_b0185","doi-asserted-by":"crossref","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","article-title":"The NHGRI GWAS Catalog, a curated resource of SNP-trait associations","volume":"42","author":"Welter","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.diabres.2022.109235_b0190","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0195","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52","author":"Bennett","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.109235_b0200","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1073\/pnas.0711232105","article-title":"Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis","volume":"105","author":"Jeffrey","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.diabres.2022.109235_b0205","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41574-020-0325-0","article-title":"Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics","volume":"16","author":"Krentz","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.diabres.2022.109235_b0210","doi-asserted-by":"crossref","first-page":"e7643","DOI":"10.1371\/journal.pone.0007643","article-title":"PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population","volume":"4","author":"Hu","year":"2009","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/srep14380","article-title":"Genetic polymorphisms of PCSK2 are associated with glucose homeostasis and progression to type 2 diabetes in a Chinese population","volume":"5","author":"Chang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.109235_b0220","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-018-0173-1","article-title":"Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic beta-cells","volume":"50","author":"Thomsen","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0168-8227(92)90060-5","article-title":"Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients","volume":"15","author":"Narita","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2022.109235_b0230","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01605927","article-title":"Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects","volume":"418","author":"Toshimori","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.diabres.2022.109235_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","article-title":"Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy","volume":"20","author":"Buse","year":"2002","journal-title":"Clinical Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.109235_b0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-8227(92)90074-2","article-title":"Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus","volume":"15","author":"Enoki","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2022.109235_b0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00592-010-0201-9","article-title":"Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus","volume":"47","author":"Zheng","year":"2010","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.diabres.2022.109235_b0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","article-title":"Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Sanke","year":"1991","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2022.109235_b0255","doi-asserted-by":"crossref","first-page":"e1003348","DOI":"10.1371\/journal.pgen.1003348","article-title":"Power and predictive accuracy of polygenic risk scores","volume":"9","author":"Dudbridge","year":"2013","journal-title":"PLoS Genet"},{"issue":"9","key":"10.1016\/j.diabres.2022.109235_b0260","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"R2","key":"10.1016\/j.diabres.2022.109235_b0265","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1093\/hmg\/ddz187","article-title":"Towards clinical utility of polygenic risk scores","volume":"28","author":"Lambert","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.diabres.2022.109235_b0270","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2018-01782","article-title":"Association Between Genetic Risk and Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study","volume":"104","author":"Inaishi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2022.109235_b0275","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.2337\/db13-0362","article-title":"Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic beta-cell function over 5 years of follow-up","volume":"62","author":"Andersson","year":"2013","journal-title":"Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272200047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:20:23Z","timestamp":1759173623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272200047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":55,"alternative-id":["S016882272200047X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109235","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common variants in genes involved in islet amyloid polypeptide (IAPP) processing and the degradation pathway are associated with T2DM risk: A Chinese population study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109235"}}